| 總結: | Patients with acute myocardial infarction (MI) complicated by cardiogenic
shock (CS) have poor prognosis. Over the last two decades, there has been some
improvement in mortality rates associated with CS. Initial measures to stabilise
patients should follow a shock protocol, including therapies such as volume
expansion, inotropes/vasopressors, and early coronary revascularisation. The use
of mechanical circulatory support (MCS) devices demonstrated better haemodynamic
and metabolic profiles for patients with CS. However, these benefits have not
been consistently translated into significant reductions in cardiovascular
adverse events. This review aims to discuss emerging concepts related to CS
including an update on its classification and pathophysiology. The focus is on
recent evidence regarding the use of MCS and the timing of initiating in patients
with CS.
|
|---|
